Show simple item record

dc.contributor.authorFerns, Helen
dc.date.accessioned2009-08-27T14:27:11Z
dc.date.available2009-08-27T14:27:11Z
dc.date.issued2003-07
dc.identifier.citationCampto effective and flexible chemotherapy for advanced colorectal cancer. 2003, 9 (7):290-7 Int J Palliat Nursen
dc.identifier.issn1357-6321
dc.identifier.pmid12920449
dc.identifier.urihttp://hdl.handle.net/10541/78907
dc.description.abstractThe use of chemotherapy with patients with advanced colorectal cancer is increasing. There is a growing appreciation of the potential of traditional and newer treatments to improve quality of life, and of their value in the palliation of symptoms, in addition to providing modest gains in overall survival. Possible benefits have to be weighed up against the risk of side effects and patients need to be supported in making difficult decisions. This article provides a brief overview of chemotherapy agents for advanced colorectal cancer and focuses on one new agent, Campto. The evidence supporting its use, common side effects and management recommendations are discussed. The role of the oncology team and the implications for nurses are outlined.
dc.language.isoenen
dc.subjectColorectal Canceren
dc.subject.meshAged
dc.subject.meshAntineoplastic Agents, Phytogenic
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols
dc.subject.meshCamptothecin
dc.subject.meshColorectal Neoplasms
dc.subject.meshFluorouracil
dc.subject.meshHumans
dc.subject.meshLeucovorin
dc.subject.meshPalliative Care
dc.subject.meshQuality of Life
dc.subject.meshRandomized Controlled Trials as Topic
dc.subject.meshSeverity of Illness Index
dc.titleCampto effective and flexible chemotherapy for advanced colorectal cancer.en
dc.typeArticleen
dc.contributor.departmentChristie Hospital NHS Trust, Manchester M20 4BX, UK.en
dc.identifier.journalInternational Journal of Palliative Nursingen
html.description.abstractThe use of chemotherapy with patients with advanced colorectal cancer is increasing. There is a growing appreciation of the potential of traditional and newer treatments to improve quality of life, and of their value in the palliation of symptoms, in addition to providing modest gains in overall survival. Possible benefits have to be weighed up against the risk of side effects and patients need to be supported in making difficult decisions. This article provides a brief overview of chemotherapy agents for advanced colorectal cancer and focuses on one new agent, Campto. The evidence supporting its use, common side effects and management recommendations are discussed. The role of the oncology team and the implications for nurses are outlined.


This item appears in the following Collection(s)

Show simple item record